[Federal Register Volume 75, Number 218 (Friday, November 12, 2010)]
[Notices]
[Page 69466]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-28531]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated March 29, 2010, and published in the Federal 
Register on April 16, 2010, (75 FR 20001), Siemens Healthcare 
Diagnostics Inc., Attn: RA, 100 GBC Drive, Mail Stop 514, Newark, 
Delaware 19702, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of the 
basic classes of controlled substances listed in schedules I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)...............   I
Ecgonine (9180)............................   II
Morphine (9300)............................   II
------------------------------------------------------------------------

    The company utilizes the listed controlled substances in bulk to 
manufacture in-vitro diagnostic test kits. The company distributes the 
test kits for sale to its customers. The process used in manufacturing 
the test kits irreversibly alters the controlled substances involved in 
such a manner that they are no longer classified as controlled 
substances as defined under the Controlled Substances Act.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Siemens Healthcare Diagnostics Inc. to manufacture the listed basic 
classes of controlled substances is consistent with the public interest 
at this time. DEA has investigated Siemens Healthcare Diagnostics Inc. 
to ensure that the company's registration is consistent with the public 
interest. The investigation has included inspection and testing of the 
company's physical security systems, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in 
accordance with 21 CFR 1301.33, the above named company is granted 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed.

    Dated: November 1, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2010-28531 Filed 11-10-10; 8:45 am]
BILLING CODE 4410-09-P